Microchip Technology Incorporated (MCHP) Cash Flow Statement

The OCF/NI ratio of 2.23 in 2027Q1, up from 1.78 in the prior quarter, indicates that earnings are translating into cash at an accelerating pace. This improvement is largely driven by a $36M positive working capital change, contrasting with the $79.8M outflow in 2026Q4, suggesting better inventory and receivables management. The gap between net income and operating cash flow has narrowed, implying higher earnings quality as the cyclical recovery matures.

The FCF trajectory shows a clear V-shaped recovery, with FCF margin expanding from 2.0% in 2025Q2 to 33.5% in 2027Q1. This rebound is supported by a 38% year-over-year revenue increase and disciplined capex, which remains below 1% of revenue. The strong FCF generation provides a cushion for dividend payments and potential debt reduction, though the sustainability of this margin depends on continued demand recovery and cost discipline.

The low capex intensity suggests that MCHP is prioritizing cash generation over aggressive investment, likely due to underutilized existing capacity. This is consistent with the gross margin expansion from 51.6% to 63.2% as utilization improves without significant new capital outlays. However, investors should monitor whether this discipline persists as demand strengthens, as underinvestment could constrain future growth.

The working capital swings have been extreme, with outflows of $235M in 2025Q2 and $204.9M in 2026Q2, reflecting the cyclical destocking and restocking phases. The recent positive change suggests that MCHP is aligning inventory with demand, reducing the risk of excess stock. This stabilization is crucial for sustaining cash flow, as volatile working capital can distort underlying earnings power.

The dividend payout ratio, based on operating cash flow, is approximately 54%, which is manageable given the strong cash generation. However, with no buybacks and minimal capex, the company is returning most of its free cash flow to shareholders. This suggests a commitment to income investors, but it also limits flexibility for debt reduction or strategic acquisitions, which could be a concern given the elevated debt/equity ratio of 0.86.

The cumulative gap of $2.02B between operating cash flow and net income underscores the importance of depreciation and amortization, which totaled over $1.8B, and the timing of working capital changes. This divergence suggests that reported earnings understate the company's cash-generating ability, but it also reflects the cyclicality of the business. Investors should focus on cash flow metrics rather than net income when assessing MCHP's financial health.